drugset / Trial / NCT00763529

Elocon vs Fluticasone in Localized Psoriasis (P03197)

NCT00763529

Phase 4 Completed 245 enrolled Organon and Co
RandomizedParallel-groupOpen-labelTreatment

Summary

This is an open-label, randomized, parallel-group clinical study. The primary objective is to assess the difference in response rate between mometasone furoate cream 0.1% (once daily) vs fluticasone propionate cream 0.05% (twice daily) by the end of Day 4 and Day 8 in the management of Indian patients with localized psoriasis.

Timeline

Start
2003-01-01
Primary completion
2005-01-01
Completion
2005-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone Other / unclassified 0.05 % Topical
Subject Mometasone Other / unclassified 0.1 % Topical

Indications